Literature DB >> 647702

Rat-colonic, mucus glycoprotein.

V L Murty, F J Downs, W Pigman.   

Abstract

A glycoprotein was isolated from rat-colonic mucosa. Analytical ultracentrifugation studies showed the glycoprotein to be homogeneous, having an apparent molecular weight of 9.0 X 10(5); no subunits could be detected in the presence of sodium dodecyl sulfate. It contained 14% of protein and 86% of carbohydrate. The principal sugars in the glycoprotein were galactose, fucose, sialic acid, 2-acetamido-2-deoxygalactose, and 2-acetamido-2-deoxyglucose. A small proportion of mannose was also present. The glycoprotein, apart from the usual carbohydrate constituents present in mucus glycoproteins, contained sulfate, but no uronic acid. High amounts of serine and threonine, and low contents of aromatic and traces of sulfur-containing amino acids, reflect a similarity of this glycoprotein to other mammalian mucus glycoproteins; it differs, however, by its high proportions of Asx + Glx (26 mol.%). Cleavage studies with alkaline borohydride indicated O-glycosidic linkages between N-acetylhexosamine and serine, and threonine, of the peptide core in the glycoprotein. Only about one third of the serine and threonine was linked to the carbohydrate side-chains, which averaged about 22 units in length and were apparently branched.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647702     DOI: 10.1016/s0008-6215(00)84474-2

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  11 in total

1.  Development of anti-human colonic mucin monoclonal antibodies. Characterization of multiple colonic mucin species.

Authors:  D K Podolsky; D A Fournier; K E Lynch
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

Review 2.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

Review 3.  Structural characterization of colonic cell types and correlation with specific functions.

Authors:  P C Colony
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

4.  Composition of human colonic mucin. Selective alteration in inflammatory bowel disease.

Authors:  D K Podolsky; K J Isselbacher
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

5.  Biochemical characterization of rat colonic mucins secreted in response to Entamoeba histolytica.

Authors:  S K Tse; K Chadee
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

6.  Independence of the activation of mucus and potassium secretion on the inhibition of sodium and water absorption by deoxycholate in rat colon.

Authors:  U M Farack; G Nell; O Lueg; W Rummel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

7.  Influence of osmolality, short chain fatty acids and deoxycholic acid on mucus secretion in the rat colon.

Authors:  K Rübsamen; H Hörnicke
Journal:  Pflugers Arch       Date:  1982-12       Impact factor: 3.657

8.  A comparison of [3H]galactose and [3H]fucose uptake with the morphological and histochemical changes observed in mucous secretion in chemically induced rat colonic carcinoma.

Authors:  P A Dawson; M I Filipe
Journal:  Histochem J       Date:  1980-01

9.  Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism.

Authors:  M Andrea Azcarate-Peril; Eric Altermann; Yong Jun Goh; Richard Tallon; Rosemary B Sanozky-Dawes; Erika A Pfeiler; Sarah O'Flaherty; B Logan Buck; Alleson Dobson; Tri Duong; Michael J Miller; Rodolphe Barrangou; Todd R Klaenhammer
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

10.  Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica.

Authors:  K Chadee; W A Petri; D J Innes; J I Ravdin
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.